Show simple item record

dc.contributor.authorHall, Sarah
dc.contributor.authorGautam, Lata
dc.contributor.authorPeng, Yan
dc.date.accessioned2020-07-02T09:07:27Z
dc.date.available2020-07-02T09:07:27Z
dc.date.issued2016-09-28
dc.identifier.citationPeng, Y., Hall, S. and Gautam. L. (2016) Drugs of abuse in drinking water - a review of current detection methods, occurrence, elimination, and health risks. Trends in Analytical Chemistry, 85, pp. 232–240en
dc.identifier.urihttps://dora.dmu.ac.uk/handle/2086/19906
dc.descriptionWith partners from the Forensic and Investigative Science Research Group, Anglia Ruskin Universityen
dc.description.abstractThis review focuses on the drugs of abuse in drinking water, as their presence is of increasing global concern and trace levels of these compounds have previously been detected. Even though these levels are not toxic with long term exposure via drinking water, they have the potential to bio accumulate and be in toxic to humans. In addition, transformation of these compounds during water treatment processes and their effect need further investigation as there are recent reports highlighting the increased toxicity to freshwater species. Currently there is limited information available on the detection of emerging drugs, therefore high resolution mass analyser could be a suitable alternative for non-target screening. Depending on the water treatment method used, the level of drugs of abuse detected can vary. Therefore, water regulatory bodies need to enforce more effective treatment methods for safe and sustainable drinking water.en
dc.language.isoenen
dc.publisherElsevieren
dc.subjectDrugs of abuseen
dc.subjectNovel psychoactive substancesen
dc.subjectDrinking wateren
dc.subjectLiquid Chromatography-Mass Spectrometryen
dc.subjectHuman Healthen
dc.titleDrugs of abuse in drinking water - a review of current detection methods, occurrence, elimination, and health risks.en
dc.typeArticleen
dc.identifier.doihttps://doi.org/10.1016/j.trac.2016.09.011
dc.peerreviewedYesen
dc.funderNo external funderen
dc.cclicenceN/Aen
dc.researchinstituteLeicester Institute for Pharmaceutical Innovation - From Molecules to Practice (LIPI)en
dc.exception.ref2021codes254aen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record